161 related articles for article (PubMed ID: 27488910)
1. Diphenhydramine as a selective probe to study H
Auvity S; Chapy H; Goutal S; Caillé F; Hosten B; Smirnova M; Declèves X; Tournier N; Cisternino S
J Cereb Blood Flow Metab; 2017 Jun; 37(6):2185-2195. PubMed ID: 27488910
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.
Cisternino S; Chapy H; André P; Smirnova M; Debray M; Scherrmann JM
AAPS J; 2013 Apr; 15(2):299-307. PubMed ID: 23212563
[TBL] [Abstract][Full Text] [Related]
3. Clonidine transport at the mouse blood-brain barrier by a new H+ antiporter that interacts with addictive drugs.
André P; Debray M; Scherrmann JM; Cisternino S
J Cereb Blood Flow Metab; 2009 Jul; 29(7):1293-304. PubMed ID: 19458607
[TBL] [Abstract][Full Text] [Related]
4. A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier.
Chapy H; André P; Declèves X; Scherrmann JM; Cisternino S
Br J Pharmacol; 2015 Oct; 172(19):4714-25. PubMed ID: 26177775
[TBL] [Abstract][Full Text] [Related]
5. Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability.
Chapy H; Smirnova M; André P; Schlatter J; Chiadmi F; Couraud PO; Scherrmann JM; Declèves X; Cisternino S
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539501
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Proton-Coupled Organic Cation Antiporter in Varenicline Transport at Blood-Brain Barrier of Rats and in Human Brain Capillary Endothelial Cells.
Kurosawa T; Higuchi K; Okura T; Kobayashi K; Kusuhara H; Deguchi Y
J Pharm Sci; 2017 Sep; 106(9):2576-2582. PubMed ID: 28454746
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of [
Savolainen H; Windhorst AD; Elsinga PH; Cantore M; Colabufo NA; Willemsen AT; Luurtsema G
J Cereb Blood Flow Metab; 2017 Apr; 37(4):1286-1298. PubMed ID: 27354093
[TBL] [Abstract][Full Text] [Related]
8. Imaging the impact of cyclosporin A and dipyridamole on P-glycoprotein (ABCB1) function at the blood-brain barrier: A [(11)C]-N-desmethyl-loperamide PET study in nonhuman primates.
Damont A; Goutal S; Auvity S; Valette H; Kuhnast B; Saba W; Tournier N
Eur J Pharm Sci; 2016 Aug; 91():98-104. PubMed ID: 27283486
[TBL] [Abstract][Full Text] [Related]
9. Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.
Tega Y; Tabata H; Kurosawa T; Kitamura A; Itagaki F; Oshitari T; Deguchi Y
J Pharm Sci; 2021 Jan; 110(1):397-403. PubMed ID: 32898521
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
Sharma V; Prior JL; Belinsky MG; Kruh GD; Piwnica-Worms D
J Nucl Med; 2005 Feb; 46(2):354-64. PubMed ID: 15695797
[TBL] [Abstract][Full Text] [Related]
11. Involvement of an influx transporter in the blood-brain barrier transport of naloxone.
Suzuki T; Ohmuro A; Miyata M; Furuishi T; Hidaka S; Kugawa F; Fukami T; Tomono K
Biopharm Drug Dispos; 2010 May; 31(4):243-52. PubMed ID: 20437463
[TBL] [Abstract][Full Text] [Related]
12. How do psychostimulants enter the human brain? Analysis of the role of the proton-organic cation antiporter.
Sachkova A; Doetsch DA; Jensen O; Brockmöller J; Ansari S
Biochem Pharmacol; 2021 Oct; 192():114751. PubMed ID: 34464621
[TBL] [Abstract][Full Text] [Related]
13. Diphenhydramine has similar interspecies net active influx at the blood-brain barrier.
Shaffer CL; Osgood SM; Mancuso JY; Doran AC
J Pharm Sci; 2014 May; 103(5):1557-62. PubMed ID: 24633923
[TBL] [Abstract][Full Text] [Related]
14. Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography.
Zhang D; Tashiro M; Shibuya K; Okamura N; Funaki Y; Yoshikawa T; Kato M; Yanai K
J Clin Psychopharmacol; 2010 Dec; 30(6):694-701. PubMed ID: 21105284
[TBL] [Abstract][Full Text] [Related]
15. Transport of diphenhydramine in the central nervous system.
Goldberg MJ; Spector R; Chiang CK
J Pharmacol Exp Ther; 1987 Mar; 240(3):717-22. PubMed ID: 3559970
[TBL] [Abstract][Full Text] [Related]
16. P-Glycoprotein (ABCB1) Inhibits the Influx and Increases the Efflux of
Auvity S; Caillé F; Marie S; Wimberley C; Bauer M; Langer O; Buvat I; Goutal S; Tournier N
J Nucl Med; 2018 Oct; 59(10):1609-1615. PubMed ID: 29748235
[TBL] [Abstract][Full Text] [Related]
17. Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography.
Sobrio F; Debruyne D; Dhilly M; Chazalviel L; Camsonne R; Kakiuchi T; Tsukada H; Barré L
Neurochem Int; 2005 May; 46(6):479-88. PubMed ID: 15769550
[TBL] [Abstract][Full Text] [Related]
18. A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids.
Cong J; Ruan Y; Lyu Q; Qin X; Qi X; Liu W; Kang L; Zhang J; Wu C
J Ethnopharmacol; 2020 Apr; 252():112581. PubMed ID: 31968215
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic study of diphenhydramine transport across the blood-brain barrier in adult sheep: potential involvement of a carrier-mediated mechanism.
Au-Yeung SC; Rurak DW; Gruber N; Riggs KW
Drug Metab Dispos; 2006 Jun; 34(6):955-60. PubMed ID: 16510542
[TBL] [Abstract][Full Text] [Related]
20. Multimodality imaging of blood-brain barrier impairment during epileptogenesis.
Breuer H; Meier M; Schneefeld S; Härtig W; Wittneben A; Märkel M; Ross TL; Bengel FM; Bankstahl M; Bankstahl JP
J Cereb Blood Flow Metab; 2017 Jun; 37(6):2049-2061. PubMed ID: 27435624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]